Journal Mobile Options
Table of Contents
Vol. 19, No. 6, 2005
Issue release date: June 2005
Cerebrovasc Dis 2005;19:376–383
(DOI:10.1159/000085543)

Early Supported Discharge for Stroke Patients Improves Clinical Outcome. Does It Also Reduce Use of Health Services and Costs?

Fjaertoft H. · Indredavik B. · Magnussen J. · Johnsen R.
Department of Public Health and Department of Neuroscience, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Background: An early supported discharge service (ESD) appears to be a promising alternative to conventional care. The aim of this trial was to compare the use of health services and costs with traditional stroke care during a one-year follow-up. Methods: Three hundred and twenty patients were randomly allocated either to ordinary stroke unit care or stroke unit care combined with ESD which was coordinated by a mobile team. The use of all health services was recorded prospectively; its costs were measured as service costs and represent a combination of calculated average costs and tariffs. Hospital expenses were measured as costs per inpatient day and adjusted for the DRG. Results: There was a reduction in average number of inpatient days at 52 weeks in favour of the ESD group (p = 0.012), and a non-significant reduction in total mean service costs in the ESD group (EUR 18,937/EUR 21,824). ESD service seems to be most cost-effective for patients with a moderate stroke. Conclusion: Acute stroke unit care combined with an ESD programme may reduce the length of institutional stay without increasing the costs of outpatient rehabilitation compared with traditional stroke care.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Evers SM, Ament A, Blaauw G: Economic evaluation in stroke research. A systematic review. Stroke 2000;31:1046–1053.
  2. Grieve R, Hutton J, Bhalla A, Rastenyte D, Ryglewicz D, Sarti C, et al: A comparison of the costs and survival of hospital-admitted stroke patients across Europe. Stroke 2001;32:1684–1691.
  3. Evers SM, Goossens ME: Economic evaluation in stroke research. An introduction. Cerebrovascular Diseases 1997;7:258–263.

    External Resources

  4. Stroke Unit Trialists’ Collaboration: A collaborative systematic review of the randomised trials of organised inpatient (stroke unit) care after stroke. BMJ 1997;314:1151–1159.
  5. Jørgensen HS, Nakayama H, Raaschou HO, Larsen K, Hubbe P, Olsen TS: The effect of a stroke unit: Reductions in mortality, discharge rate to nursing home, length of hospital stay, and cost. A community-based study. Stroke 1995;26:1178.
  6. Early Supported Discharge Trialists: Services for reducing duration of hospital care for acute stroke patients. The Cochrane Library, update software, issue 3, 2002.
  7. Beech R, Rudd AG, Tilling K, Wolfe CDA: Economic consequences of early inpatient discharge to community-based rehabilitation of stroke in an inner-London teaching hospital. Stroke 1999;30:729–735.
  8. Anderson C, Mhurchu CN, Rubenach S, Clark M, Spencer C, Winsor A: Home or hospital for stroke rehabilitation? Results of a randomized controlled trial. 2. Cost minimization analyses at 6 months. Stroke 2000;31:1032–1037.
  9. McNamee P, Chrjstensen J, Soutter J, Rodgers H, Craig N, Pearson P, Bond J: Cost analyses of early supported hospital discharge for stroke. Age Ageing 1998;27:345–351.

    External Resources

  10. Teng J, Mayo N, Latimer E, Hanley J, Wood-Dauphinee S, Cote R, Scott S: Costs and caregivers consequences of early supported discharge for stroke patients. Stroke 2003;34:528–536.
  11. von Koch L, de Pedro-Cuesta J, Kostulas V, Almazan J, Widen Holmqvist L: Randomized controlled trial of rehabilitation at home after stroke: One-year follow-up of patient outcome, resource use and cost. Cerebrovasc Dis 2001;12:131–138.
  12. Indredavik B, Fjærtoft H, Ekeberg G, Løge A, Mørch B: Benefit of an extended stroke unit service with early supported discharge: A randomized, controlled trial. Stroke 2000;31:2989–2994.
  13. Fjærtoft H, Indredavik B, Lydersen S: Stroke unit care combined with early supported discharge: Long-term follow-up of a randomized controlled trial. Stroke 2003;34:2687–2692. Editorial comment by Langhorne, p 2692.
  14. Fjærtoft H, Indredavik B, Johnsen R, Lydersen S: Acute stroke unit care combined with early supported discharge. Long-term effects on quality of life. A randomized controlled trial. Clin Rehabil 2004;18:580–586.
  15. Indredavik B, Bakke F, Solberg R, Rokseth R, Håheim LL, Holme I: Benefit of a stroke unit: A randomized controlled trial. Stroke 1991;22:1026–1031.
  16. Brouwer W, Rutten F, Koopmanschap M: Costing in economic evaluations; in Drummond M, McGuire A (eds): Economic Evaluation in Health Care. Merging Theory with Practice. Oxford, Oxford University Press, 2001.
  17. Spieler JF, Lanoe JL, Amarenco P: Costs of stroke care according to handicap levels and stroke subtypes. Cerebrovasc Dis 2004;17:134–142.
  18. Heyse JF, Cook JR, Carides GW: Statistical considerations in analysing health care resource utilization and cost data; in Drummond M, McGuire A (eds): Economic Evaluation in Health Care. Merging Theory with Practice. Oxford, Oxford University Press, 2001.
  19. Chang MN, Guess HA, Heyse JF: Redustion in burden of illness: A new efficacy measure for prevention trials. Stat Med 1994;13:1807–1814.
  20. Anderson C, Ni Mhurchu C, Brown PM, Carter K: Stroke rehabilitation services to accelerate hospital discharge and provide home-based care: An overview and cost analysis. Pharmacoeconomics 2002;20:537–552.
  21. Jørgensen HS, Nakayama H, Raaschou H, Olsen TS: Acute stroke care and rehabilitation: An analysis of the direct costs and its clinical and social determinants. The Copenhagen Stroke Study. Stroke 1997;28:1138–1141.


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50